SCHEMBL3080181

SCHEMBL3080181

O=C(O)c1ccc2cc3n(c2c1)C(=O)CNCc1ccccc1-3

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.40
SRD5A1 P18405 1/20 0.40
POLB P06746 2/20 0.37
KMT2A Q03164 2/20 0.37
TTR P02766 1/20 0.37
PTPRC P08575 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
AURKA O14965 2/20 0.35
RPS6KA3 P51812 1/20 0.35
RPS6KA2 Q15349 1/20 0.35
ACLY P53396 2/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
SLC11A2 P49281 1/20 0.34
TSHR P16473 1/20 0.33
MEN1 O00255 1/20 0.33
PKM P14618 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3092044 0.79 RPS6KA2 (0.43) SRD5A2SRD5A1RPS6KA3RPS6KA2
SCHEMBL3081008 0.76 SRD5A2 (0.38) SRD5A2SRD5A1POLBKMT2ATTR
SCHEMBL3083812 0.76 RPS6KA2 (0.43) SRD5A2SRD5A1RPS6KA3RPS6KA2
SCHEMBL3073902 0.76 RPS6KA2 (0.41) SRD5A2SRD5A1POLBKMT2ATTR
SCHEMBL3089903 0.74 RPS6KA2 (0.44) SRD5A2SRD5A1RPS6KA3RPS6KA2
SCHEMBL3092098 0.74 SRD5A2 (0.36) SRD5A2SRD5A1KDM4ERPS6KA3RPS6KA2
SCHEMBL4144545 0.72 RPS6KA2 (0.36) SRD5A2SRD5A1RPS6KA3RPS6KA2
SCHEMBL3943354 0.71 SRD5A2 (0.48) SRD5A2SRD5A1POLBKMT2ATTR
SCHEMBL3574670 0.71 SRD5A2 (0.50) SRD5A2SRD5A1ALDH1A1RPS6KA3RPS6KA2
SCHEMBL3244153 0.71 SRD5A2 (0.43) SRD5A2SRD5A1POLBKMT2ATTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795247-B2 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-09-14 US disclosed
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHEDI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IRMB) (IT) 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents IDO1, ZC3HAV1, IDO2 SRD5A2 406/4885SRD5A1 308/4885POLB 4258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.